Raw athletic power meets grace under pressure in the third season of smash hit CBC series Battle of the Blades which partners the stars of hockey and figure skating in a weekly live skating competition for $100,000 first prize donation to the charities of their choice.
This year’s cast includes Tanith Belbin, five-time U.S. Ice Dance Champion, four-time World Medalist and 2006 Olympic Silver Medalist, who has chosen to skate for The Montreal Neurological Institute and Hospital – The Neuro at McGill University. Her partner is former NHL player Boyd Devereaux who is skating for Epilepsy Huron-Perth-Bruce.
The Gemini Award-winning series which began September 25 will feature performance shows on Sunday nights at 8pm, followed by live “skate-off” results shows on Monday nights at 8pm, until the new champions are crowned. The season finale is on November 14.
How to vote (after each Sunday performance show from 7pm to 2am ET) :
-phone: dial 877-844-8152 for Tanith Belbin and Boyd Devereaux
About Battle of the Blades:
For more information about the competitors, please visit the official online portal of BATTE OF THE BLADES, www.cbc.ca/battle, produced by Insight Productions in association with CBC Television.
The Montreal Neurological Institute and Hospital:
The Montreal Neurological Institute and Hospital — The Neuro, is a unique academic medical centre dedicated to neuroscience. The Neuro is a research and teaching institute of McGill University and forms the basis for the Neuroscience Mission of the McGill University Health Centre. Founded in 1934 by the renowned Dr. Wilder Penfield, The Neuro is recognized internationally for integrating research, compassionate patient care and advanced training, all key to advances in science and medicine. Neuro researchers are world leaders in cellular and molecular neuroscience, brain imaging, cognitive neuroscience and the study and treatment of epilepsy, multiple sclerosis and neuromuscular disorders. The Montreal Neurological Institute was named as one of the Seven Centres of Excellence in Budget 2007, which provided the MNI with $15 million in funding to support its research and commercialization activities related to neurological disease and neuroscience.